Literature DB >> 1096899

Conjugation of L-DOPA and its metabolites after oral and intravenous administration to Parkinsonian patients.

R L Bronaugh, R J MacMurtry, M M Hoehn, C O Rutledge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1096899     DOI： 10.1016/0006-2952(75)90345-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetics of levodopa in parkinson's disease.

Authors:  J R Bianchine; G M Shaw
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

2.  Platelet phenolsulphotransferase activity in Parkinson's disease.

Authors:  V Glover; A J Lees; C Ward; G M Stern; M Sandler
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

3.  Measurement and kinetic study of the formation of adrenaline sulphate in vitro.

Authors:  K P Wong
Journal:  Biochem J       Date:  1978-09-15       Impact factor: 3.857

Review 4.  The Human Experience with Intravenous Levodopa.

Authors:  Shan H Siddiqi; Natalia K Abraham; Christopher L Geiger; Morvarid Karimi; Joel S Perlmutter; Kevin J Black
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.